Skip to content
Home/Companies/Biotech/Targed
Targed

Targed

Biotech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Targed?

Targed is currently owned by Andera Partners through BioDiscovery 6 (2022 vintage), since 2022.

Hand-verified · updated 2026-04-21

Andera Partners
Investor
Andera Partners
BioDiscovery 6 · 2022 · VC

Key facts

HQFrance
SectorBiotech
Websitetargedbiopharmaceuticals.com

More from BioDiscovery 6

Other portfolio companies in the same fund.

Inventiva
Inventiva
Active
BiotechFrance· 2024
Kestra Medical Technologies
Kestra Medical Technologies
Active
MedTechUS· 2024
SciRhom
Active
BiotechFrance· 2024
Abivax
Abivax
Active
BiotechFrance· 2023
Ariceum
Active
BiotechFrance· 2023
BioVentrix
BioVentrix
Active
MedTechFrance· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Targed

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Targed?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Targed.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue